Clinical Trials Browser

Not yet recruiting × surufatinib × Thoracic × Clear all

NCT06414915 2024-05-16

Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation

Phase 2 Not yet recruiting

NSCLC

NCT05882630 2023-05-31

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Phase 1/2 Not yet recruiting

Small Cell Lung Carcinoma